Leaflet TICLID 250mg film-coated tablets
Indicated for: prevention of atherothrombotic events
Route of administration: oral
Substance: ticlopidine (anticoagulant)
ATC: B01AC05 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
This medicine is subject to additional monitoring.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of bleeding.
Ticlopidine is an antiplatelet medication used to prevent blood clots (thrombosis) in conditions with a high risk of thrombotic events, such as ischemic strokes, myocardial infarction, or arterial thrombosis. It works by inhibiting platelet aggregation, blocking receptors on the surface of platelets, and preventing clot formation.
Ticlopidine is often used in patients who cannot tolerate other antiplatelet medications, such as aspirin, or in combination with other treatments to reduce the risk of cardiovascular complications. It is taken orally, usually twice daily, as prescribed by a doctor.
Common side effects include nausea, diarrhea, abdominal pain, and skin rashes. In rare cases, it can cause serious adverse effects, such as agranulocytosis (a severe drop in white blood cells), thrombocytopenia (low platelet count), or thrombotic thrombocytopenic purpura (TTP). For this reason, regular blood count monitoring is required during treatment. Ticlopidine is contraindicated in patients with bleeding disorders, active bleeding, or severe liver impairment.
General data about TICLID 250mg
- Substance: ticlopidine
- Date of latest medicines list: 01-07-2013
- Product code: W53454001
- Concentration: 250mg
- Pharmaceutical form: film-coated tablets
- Quantity: 20
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.